Objective: To test if visual focusing and mimic display as features of self-regulation in ADHD children show a curvilinear relation to rising methylphenidate (MPH) doses. To test if small dose steps of 2.5mg MPH cause significant changes in behavior. And to test the relation of these features to intellectual performance, parents' ratings, and clinical outcome. Method: Twenty-five children of a clinical convenience sample are filmed playing cards and doing oral arithmetic exercises without medication and after intake of MPH raised in steps of 2.5 mg. Recordings are revised by four blinded raters counting visual focus loss and rating the variability of patients' smile. Results: All hypotheses are confirmed. Best self-regulation coincides with best intellectual performance, highly significant improvement in parents' ratings, and good clinical outcome. Conclusion: The procedure could be helpful for MPH dose finding in the physician's practice and make therapy more efficient by means of a more precise dosage. (J. of Att. Dis. 2007; 10(4) 
A DHD is not only characterized by repeated behavioral patterns as described by the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) criteria for inattention, hyperactivity, and impulsivity. Neurophysiologic correlates of information processing as well as reaction time tasks show significant alterations and improvement after methylphenidate (MPH) therapy in ADHD children (Barkley, Edwards, Laneri, Fletcher, & Metevia, 2001; Coons et al., 1981; Halliday, Callaway, & Naylor, 1983; Jonkman et al., 2000; Kenemans et al., 2005; van Leeuwen et al., 1998) . ADHD children also showed significant differences to unaffected children in various short-term behavioral patterns (Borger, & van der Meere, 2000; Flintoff, Barron, Swanson, Ledlow, & Kinsbourne, 1982) . Deficits and their improvement with MPH are not limited to perceptive and executive functions (Rhodes, Coghill, & Matthews, 2005) . Self-regulatory processes of emotions and motivation are also affected in ADHD, and there is evidence for improvement of these functions with MPH therapy (Berlin, Bohlin, Nyberg, & Janols, 2004) .
Fritz Jansen (Jansen & Streit, 1992) observed eye movements outside the fixation point in communicative situations and while carrying out academic tasks as well as alterations in facial expression of emotions in ADHD children. In a former study (Kühle, Hoch, Rautzenberg, & Jansen, 2001 ) using video-assisted behavior observation, we determined 22 items of visual attention, facial expression, and motor behavior typical of ADHD children within a time frame of milliseconds to seconds. To study their relationship to ADHD, we compared the frequency of these items in ADHD children to those of an age-and sexmatched control group of children with a common cold. The children were recorded playing cards with their mothers for 2 min and while doing 2 min of oral arithmetic exercises. The sequences were mixed at random and sent to two raters who did not know the patients. There was a high correlation (r > .75) between the ratings, and almost all of the items were highly significantly more frequent in ADHD children than in the control group. The main features that distinguished ADHD children from unaffected children were interruption of visual focusing; an abrupt, brusque, and oversized smile, with a longer duration than the social situation that evoked it; and an altered quality of goal movements: Movements were brusque, too quick, and with too much effort, exceeding their goal and thus needing many corrections. Whereas the interruption of visual focusing and the mimic alterations could be observed in all patients, there were many movement characteristics typical for ADHD, and each patient revealed only particular features.
In our clinical practice, we observed that the interruptions of visual focusing and mimic alterations were reduced under medication with MPH. There seemed to be an "optimal dose" where these features almost disappeared. With lower or higher MPH doses, frequency of the alterations augmented. We therefore began to use these observations in more and more standardized video sequences for dose finding, in addition to common clinical procedures such as reports by parents and teachers and intellectual performance at school. In this study, we tried to prove our clinical observations in a blinded design to test the following hypotheses: Visual focusing and mimic display as features of self-regulation show a curvilinear relation to rising MPH doses. Small dose steps of 2.5 mg MPH cause significant changes in behavior in ADHD children. When defining the dose at the turning point of the U function as the individually best dose and using this dose for therapy, intellectual performance is good as well as parents' ratings and longer term outcome measures.
Method
Twenty-five children of a clinical convenience sample were filmed playing cards with their mothers and doing oral arithmetic exercises appropriate to their school level without medication and 75 min after intake of an immediately released MPH preparation (Ritalin, Medikinet, or Equasym) . Doses were raised in steps of 2.5 mg MPH for each recording until we recognized signs of an overdose. Two-minute sections of the card-playing situation were copied on a tape in random sequence and sent to four raters who knew neither patients nor doses. Raters counted the numbers of loss of visual focus and rated the variability of patients' smile on a 5-point scale. ANCOVA was used to reveal main tendencies and confounding variables; Paired differences were tested for significance by student's t test. Then, results were compared to findings in the arithmetic exercises, to clinical outcome, and to parents' ratings before and after more than 5 months of therapy with the determined MPH dose.
Sample
The sample consisted of 25 patients from our practice: 19 boys and 6 girls, with a mean age of 10 years 4 months, who asked for help because of learning and behavioral problems in school and at home. Characteristics of the patients are displayed in Table 1 .
Diagnostics
Children were diagnosed for ADHD by their clinical history and by behavior observation. Both were evaluated especially to exclude pervasive psychiatric and neurological disorders. Parents' ratings were obtained at the moment of diagnostics and at least 5 months after treatment with the individual dose determined by the above-mentioned procedure. Parents' ratings contained statements to the 18 DSM-IV symptoms for inattention, impulsivity, and hyperactivity in a German translation of the ADHD questionnaire of Dupaul, Power, and Anastopoulos (1998) . Neuropsychological testing was done at a second date using mostly Catell's Culture Fair Test, which contains ageadequate logical procedures but has no verbal section.
Selection of Patients for the Sample
We revised our patient records for all those patients who had completed preferably six, but at least five, recordings with different MPH doses back from December 2003 up to a number of 25 patients. In our clinical practice, we often have to do only four to five recordings until we know the individual best dose and to observe discrete overdose signs. Therefore, our selection criterion was the number of completed recordings.
Definition of the Optimal Dose
Children were filmed with rising MPH doses. Visual focusing and variability of smile improved but worsened with higher doses. The turning point of this curvilinear relation was defined as the individual optimal dose. Between the individuals, we observed a range between 5 and 20 mg MPH with a mean of 12.5mg. We put recordings of the individual "optimal dose" and with 2.5 and 5mg MPH below and above that dose and a recording without medication in random sequence on the tape for the raters. All parents, as well as the patients older than 12 years old, gave their consent to the study.
Dependent Measures and Rating Criteria
As our dependent measures, raters had to count all interruptions of focusing and to rate the variability of the smiles on a 5-point scale ranging from (1) an oversized and tense smile with abrupt onset and offset to (5) a fine and variable smile with smooth onset and offset. To rate intellectual performance, we counted the number of correct solutions obtained in the oral arithmetic exercises under all dosage conditions.
Training of the Raters
Raters were members of a cooperative network of professionals working with ADHD children. Rater 1 (female, educationalist) and Rater 2 (male, pediatrician) had completed a weekend of training in the recognition of the mentioned 22 involuntary ADHD signs 1 year before the study began. Rater 1 works daily with the video-assisted observation of ADHD children; Rater 2 has used video-assisted observation infrequently. Rater 3 (male, psychiatrist) and Rater 4 (female, psychologist) both took part in a weekend of training in the recognition of variability of facial expression of emotions and smiles immediately before they started scoring the videos. Rater 3 had no prior experience in video-assisted observation; Rater 4 used video-assisted observation in her daily work. The raters therefore had differing levels of experience and had had different training conditions. All training had been carried out on patients who did not participate in this study.
Statistics
The statistical analyses were conducted on 25 patients, with five to six dosage steps and four raters. Analyses of covariance (ANCOVA) were used to analyze the differences between the mean ratings of mimic variability (N = 568) and the ratings of interruptions of visual focusing (N = 567) for all steps of dosage. To control potential confounders, we used the variables sex, age, and rater as covariates. Student's t tests for paired differences were calculated to test the significance of the different steps of dosage. Interrater reliability was assessed with intraclass correlation.
Results
The ANCOVA confirmed a highly significant relation between the mean frequencies of interruptions of visual focusing, F (5/558) = 11.79, p < .001, and the MPH dose, as well as a highly significant relation between the mean ratings of mimic variability, F (5/559) = 55.67, p < .001, and the MPH dose.
Interruptions of Visual Focusing
Using the student's t test for paired differences, it was examined between which dosage steps the differences in the mean frequencies of interruptions were statistically significant. At optimal dose and with -2.5mg and 2.5 mg suboptimal dose, the number of interruptions was lowest, and differences between optimal and -2.5 mg and 2.5 mg suboptimal dose were not significant. There was a significant difference between -5 mg suboptimal dose (p < .01) and the optimal dose. In the condition without medication (p < .001), significantly more interruptions of visual focusing were counted than in all the other dosage conditions. There were low but significant influences of the variables sex (p < .01) and rater (p < .05) on the mean frequencies of interruptions of visual focusing. Figure 1 displays the means of the frequency of interruptions of visual focusing in relation to MPH dose. The graph has the form of an U function.
Variability of Facial Expression
Again, the student's t tests for paired differences were calculated to examine between which dosage steps the mean estimations of mimic variability were statistical significant. At optimal dose and with -2.5 mg and 2.5 mg suboptimal doses, the raters considered the smile most fine and variable; differences between optimal and -2.5 mg and 2.5 mg suboptimal dose were not significant. There was a significant difference between -5 mg (p < .01) and the optimal dose and between 5 mg (p < .05) and the optimal dose. In addition, the condition without medication (p < .001) differed significantly from the optimal dose. No significant influences of the covariates (sex, age, and rater) were observed concerning the ratings of mimic variability. The graph of the mean variability of facial expression in relation to the MPH dose shows an inverted U function (see Figure 2) . Note: 1) 0mg < −5mg; −2.5mg; optimum; +2.5mg and +5mg; 2) −5mg < optimum; 3) +5mg < optimum ***p < .001. **p < .01. *p < .05
MPH Dose-Related Changes in Intellectual Performance
We reviewed the number of correct solutions obtained from 2 min of oral arithmetic exercises in relation to the MPH dose for the 25 children (see Figure 3) . The student's t test for paired differences revealed that all steps below and above the optimal dose were statistically significant. Math tests serve as a good indicator for academic performance (Fischer & Newby, 1998; Volkow et al., 2004) . Best self-regulation of emotional expression coincides with best intellectual performance as shown in oral arithmetic exercises. Even such small steps in the MPH dose as 2.5 mg of the single dose MPH cause significant performance effects.
Training of the Raters
There was a medium intraclass correlation between all raters counting the interruptions of visual focusing of mostly r = .5, p < .01. Raters 1 to 3 showed higher correlations in their ratings for most of the dosages with r > .8, p < .001, whereas Rater 4 did not show a high correlation in the paired comparisons with the other raters.
Although the ratings of mimic variability of all four raters together showed the mentioned significant accordance with our determinations, there was no high correlation between the four raters. Rater 2 almost only distinguished between the condition without or with medication; Rater 4 considered more frequently mimic variability optimal at higher MPH level. Only Raters 1 and 3 showed medium correlations of r = .5, p < .05, in most of the medication conditions.
Relation to Parents' Ratings and Clinical Outcome
The clinical outcome is described in Table 1 . Shortterm effects were good, with the exception of Patient 25. Patient 19 dropped out after 1 month, 2 others completed only a few months, and 22 of 25 patients took MPH in doses determined by our procedure for 1 year to more than 5 years. They stayed with the same dose except for one of those patients who changed to an extended release MPH preparation and one patient who augmented each single dose by 2.5 mg.
A significant change in the mean frequencies of the DSM-IV symptoms for inattention was observed during 
Discussion
The results confirm our hypotheses. There is a curvilinear relation between MPH doses, interruptions of visual focusing, and variability of facial expression of emotions. Moreover, there is an inverse curvilinear relation between MPH doses and performance in oral arithmetic exercises. Both curves have their turning point at the same dose. Best self-regulation coincides with best access to intellectual capacities.
The mentioned MPH doses are single doses taken three to four times a day. When related to body weight, doses correspond to the daily doses of the medication management group in the MTA study (Jensen, 2002) . ADHD children who were treated with MPH doses determined by the mentioned procedure have a good outcome, and their behavior is rated significantly better in parents' ratings.
Hence, from our practical observations, we developed a procedure that could be confirmed in a blinded design. A dose-finding procedure easy to use in the physician's practice has been desired for years already (e.g., Johnson, 1997) . As explained above, there are many results indicating alterations of self-regulation in ADHD. Our method is based on the observation of behavioral changes caused by changes in the state of self-regulation. It is also more easily applicable. Problems arise, however, if raters do not have good training. We hope to improve interrater reliability through better training. Rater 3 made us think that this is possible.
Sample size was small and it was not a prospective double-blind study. Influences of the treating person may have been a bias, but it was always the same pediatrician who treated patients. All of them received parents' counseling and individual counseling. No one received a more intense behavior therapy during the studied course of time.
There are some observations of our clinical practice with the mentioned procedure that are noteworthy: Parents change their behavior toward the child when their child shows fine mimic variability. They often became relaxed and happy. We always also recorded the mother's face. The better mood is not only displayed in the face but also by the sound of the voice, so we could note how interaction improved as a function of MPH dosage. At suboptimal over or under doses, we noted the reappearance of irritation. This may also be important for the child's situation at home and in the peer group. We also noticed a smile when children gave correct answers during the oral arithmetic exercises at "optimal dose." They expressed that pleasure before sensitive mothers were able to reinforce them. They seem to feel that they have easier access to their abilities with the relative best MPH dose. This fosters achievement motivation, which is threatened by the failure ADHD children often experience in spite of all their efforts. As performance is better even with too high doses than with too low doses, we think that only counting the number of correct answers would be misleading, if it would be used to determine the individual best dose.
This study wants to expose a new method of MPH dose finding in the physician's practice. The method was derived from clinical observations and now proven in a blinded design. We hope to reduce interrater differences with improved training so that video-assisted observation of visual focusing and variability of smile may become a useful tool to determine a good state of selfregulation. This may make MPH therapy in ADHD children more efficient by means of a more precise dosage.
